We previously demonstrated that metformin exerts anticancer metabolic effect on unsorted breast cancer cell populations by broadly modulating the metabolic pathways, at least partially in a DICER-dependent microRNA modulation[15]. Here, DICER1 is linked to breast carcinoma.